Breaking News

PTI Appoints President and COO

By Kristin Brooks | January 9, 2014

Mitchell brings 25 years of finance experience

Anthony (Tony) Mitchell has been appointed president and chief operating officer of Pharma Tech Industries (PTI). Mr. Mitchell will be responsible for short and long-term strategic growth plans as well as further enhancing the company’s business models for maximum growth potential.
Mr. Mitchell will also foster skill set growth among the workforce of more than 350 specialists in two facilities for PTI’s varied production environments, including the manufacture and packaging of Rx, OTC, medical devices, cosmetics and consumer disposables.
Mr. Mitchell has more than 25 years of business management experience. He joins the company from Morrison Management Specialists, where he most recently served an eight-year tenure as chief financial officer.
Mr. Mitchell joins the company during a period of growth with expanded and upgraded capabilities and services. PTI recently expanded its on-site testing capabilities at its Royston, GA plant and is currently expanding its production facility in Union, MO. The investment will add approximately 60,000 sq. ft. of manufacturing space, which will be used primarily for the production of ingestible powders and include a production room built to ISO8/100,000 cleanroom standards. The project is scheduled to be completed in March 2014.
“As Pharma Tech Industries continues to enhance and expand its facilities, offer new services and take on newer and bigger customers, we need a dedicated business leader to help us grow strategically and effectively,” said Tee Noland, chairman of Pharma Tech Industries. “Tony has a tremendous reputation for building world class organizations, and is a welcome addition to the PTI family.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks